Market Overview

The Australia animal health market size reached USD 779.8 Million in 2024 and is projected to reach USD 1,001.6 Million by 2033, with a CAGR of 2.80% during the forecast period 2025-2033. Market growth is driven by rising pet ownership, demand for livestock disease management, biosecurity regulations, veterinary technological advancements, and increasing awareness of zoonotic diseases. Government initiatives and export-focused livestock industries also support this expansion.

Find more details at the Australia Animal Health Market https://www.imarcgroup.com/australia-animal-health-market

How AI is Reshaping the Future of Australia Animal Health Market:

• AI-enabled telehealth platforms enhance veterinary access in rural and underserved regions by providing remote consultations, prescription renewals, and follow-ups.
• The launch of the "Animal Disease Insights" dashboard by One Health Epi Consulting uses AI to consolidate global animal disease data, supporting professionals in surveillance and disease management.
• AI-based diagnostics and rapid testing kits improve the precision and efficiency of treatments in companion and commercial animal health sectors.
• Government funding, such as an additional AUD 95 Million for biosecurity measures, supports AI-driven surveillance and response systems for outbreaks like avian influenza.
• Large industry players invest heavily in AI research to innovate advanced therapeutics and local manufacturing, exemplified by Zoetis Australia's AUD 350 Million facility expansion.
• Wearable AI technologies for pets and livestock enable real-time health monitoring, aiding preventive care and minimizing treatment delays.

Grab a sample PDF of this report: https://www.imarcgroup.com/australia-animal-health-market/requestsample

Market Growth Factors

The Australian pet ownership rate continues to grow, a key factor in the growth of the country animal health market, and pet owners are increasingly regarding their animals as family members, greatly increasing expenditure on veterinary services, vaccines, and preventative and wellness products. Furthermore, increased companion animal insurance penetration has enabled the use of high-priced medical treatment and diagnosis, while chronic diseases and general market fluctuations can be limited by preventive healthcare. Introducing preventive medicine and changing consumer attitudes widened the customer base within the market creating opportunities for specialized veterinary and healthcare service providers.

Better disease therapeutics and management open markets through technology. This includes new imaging technologies, rapid test kits, telemedicine, and artificial intelligence applications that aid in the accurate diagnosis of diseases. Wearable technology for animals provides real-time information that aids in scheduling pet visits, preventive care, push for better services, and reduced wait times which is expected to aid market growth in the wearable technology for animals market.

Government policies, including biosecurity, animal welfare and food safety laws, can therefore play a very important role in the animal health market, with livestock disease control, zoonotic risk monitoring and veterinary infrastructure key priorities. Funding such as the AUD 95 Million to increase preparedness against avian influenza has increased national biosecurity and focused on vaccination. Strong animal welfare laws also drive demand for veterinary compliance, industry stability, and consumer confidence in the industry's ability to provide animal care services.

Market Segmentation

Animal Type Insights:

• Commercial
• Companion

Product Type Insights:

• Pharmaceuticals
• Biologicals
• Medicinal Feed Additives
• Diagnostics

Regional Insights:

• Australia Capital Territory & New South Wales
• Victoria & Tasmania
• Queensland
• Northern Territory & Southern Australia
• Western Australia

Key Players

• Ceva Santé Animale
• Scout Bio
• Zoetis Australia

Recent Developement & News

• March 2025: One Health Epi Consulting launched "Animal Disease Insights," an AI-powered online dashboard that consolidates global animal disease trends and outbreak data, aiding professionals in surveillance and management with plans to incorporate real-time social media insights.
• March 2025: Zoetis Australia announced an investment of up to AUD 350 Million to establish operations and expand manufacturing capabilities in Parkville, Victoria, bolstering local vaccine and diagnostic production and supporting Australia's health technology sector.
• October 2025: The Australian Government allocated an additional AUD 95 Million to enhance preparedness for high pathogenicity avian influenza (HPAI) H5N1, focusing on biosecurity response systems, surveillance, scientific infrastructure, and vaccine acquisition to protect agriculture and native wildlife.

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

https://www.imarcgroup.com/request?type=report&id=31605&flag=F

About Us

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provides a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us

IMARC Group,

134 N 4th St. Brooklyn, NY 11249, USA,

Email: sales@imarcgroup.com,

Tel No: (D) +91 120 433 0800,

United States: +1-201971-6302